Cibus, Inc. (NASDAQ: CBUS)

Cibus, Inc. specializes in agricultural biotechnology, focusing on the development and commercialization of gene-edited crops through its proprietary Rapid, Targeted, and Stable (RTDS) gene-editing platform. The company operates within the agricultural biotechnology sector, aiming to enhance crop productivity, sustainability, and resilience through innovative genetic modifications. Cibus leverages advanced gene-editing techniques to create non-transgenic crop varieties that offer improved traits such as disease resistance, herbicide tolerance, and yield enhancement.

Cibus generates revenue primarily through licensing its gene-edited crop traits to seed companies and agricultural producers. The company's key products include its RTDS gene-editing technology and a pipeline of productivity traits designed for various crops. These traits are developed to address specific agricultural challenges, such as disease resistance and herbicide tolerance, and are licensed to seed companies for integration into their breeding programs. Cibus's customer base consists of leading seed companies and agricultural producers seeking to enhance crop performance and sustainability.

• RTDS Gene-Editing Platform: This proprietary technology enables precise, non-transgenic genetic modifications in crops, allowing for the development of traits that could not be achieved through conventional breeding. The platform is integral to Cibus's trait development and commercialization efforts, catering to the global agricultural market.

• Productivity Traits Pipeline: Cibus has developed a pipeline of productivity traits, including disease resistance and herbicide tolerance traits, designed to enhance crop performance. These traits are licensed to seed companies for integration into their breeding programs, serving the global agricultural market.

Cibus, Inc. holds a competitive position in the agricultural biotechnology industry, distinguished by its RTDS gene-editing platform and non-transgenic crop traits. The company faces competition from major agricultural chemical companies such as BASF, Bayer Crop Science, Corteva AgriScience, and Syngenta, as well as smaller biotechnology research companies and academic institutions. Cibus's competitive advantages include its non-transgenic categorization in key target markets, which allows for faster and more cost-effective product commercialization. The company's premier management team, with extensive industry experience, further strengthens its competitive position.

Cibus, Inc. serves a diverse customer base, including leading seed companies and agricultural producers seeking to enhance crop performance and sustainability. The company's products are designed to address specific agricultural challenges, such as disease resistance and herbicide tolerance, catering to the global agricultural market.